Today: 9 April 2026
Sky Is No Limit: Global Satcom Market Set to Soar Through 2035
2 October 2025
3 mins read

AST SpaceMobile (ASTS) Stock Skyrockets on New Satellite and Carrier Milestones – Record Highs and $60+ Targets

  • Ticker/Market Cap: AST SpaceMobile (NASDAQ: ASTS) is a Texas-based satellite-communications company building a space-based cellular broadband network for unmodified smartphones businesswire.com. As of early October 2025, its market cap was in the low-$20 billion range (recent high near $21.6B) za.investing.com.
  • Stock Performance: ASTS has surged in 2025, gaining roughly 130% YTD (52-week range ~$17.5–$61) webull.com za.investing.com. On Oct 1, 2025 the stock jumped ~16% on an unusually large volume(~20.1 million shares, ≈$1.09 billion traded) ainvest.com stockanalysis.com. It then set an all-time high near $61.18on Oct 2 za.investing.com. For context, ASTS has roughly doubled in price in 2025 stocktwits.com and now trades at ~5× its October 2024 level.
  • Key Partnerships: AST has secured major carrier partnerships. Notably, Bell Canada (via Bell Ventures) reported a successful space-based 4G VoLTE call using AST satellites and plans to deploy nationwide service in 2026 newswire.ca. Bell’s CTO called it “a breakthrough moment for connectivitynewswire.ca. In Europe, AST’s SatCo JV with Vodafone has drawn interest from operators in most EU countries. In India, the Vodafone-Idea (“Vi”) partnership will address one of the world’s largest markets businesswire.com. Overall, ASTS reports agreements with 50+ mobile network operators globally (≈3.0 billion subscribers) businesswire.com. U.S. and NATO defense contracts (via the Defense Innovation Unit and others) also underwrite its military/business pipeline businesswire.com.
  • Technology & Launches: ASTS is building large “BlueBird” satellites (each ~2,400 ft² phased array) to deliver direct-to-cell broadband (~120 Mbps peak) webull.com stocktwits.com. BlueBird-6 (a Block-2 satellite) completed final assembly and is slated to fly to India on Oct 12, 2025 webull.com stocktwits.com. BlueBird-7 will ship to Cape Canaveral shortly after, and satellites 8–16 are in production, with launches planned every 1–2 months through 2025–2026 webull.com stocktwits.com. Management reiterates a “fully-funded plan to deploy 45 to 60 satellites into orbit by 2026” with regular launches businesswire.com. The FCC recently approved 20 of AST’s satellites for launch (subject to conditions) stocktwits.com.
  • Spectrum / Regulation: In mid-2025 AST secured new spectrum: it agreed to acquire global S‑Band rights (1.98–2.01 GHz uplink, 2.170–2.200 GHz downlink) for ~$64.5M businesswire.com. CEO Abel Avellan noted these S‑Band rights, combined with AST’s planned L‑Band access, will enable a “true broadband experience” up to 120 Mbps from space businesswire.com. AST also finalized U.S./Canada L‑Band agreements (~45 MHz of premium mid-band) via court approval businesswire.com.
  • Financials: ASTS is not yet profitable. In Q2 2025, it reported EPS –$0.41 on $1.15 million revenue – far below consensus (EPS miss ~95%, revenue miss ~79%) investing.com. OpEx was high (≈$74M/qtr) as AST ramps satellites. As of June 30, 2025, AST had $939.4 M cash on the balance sheet businesswire.com; after a $575M convertible debt raise and other financings it pro forma holds >$1.5 billion businesswire.com. Management reiterates expectations for $50–75 M in revenue in H2 2025 (from both government and commercial sources) businesswire.com. (Q3 results are due Nov 13, 2025.)
  • Analysts & Targets: Wall Street views ASTS as a high-growth/high-risk play.  Barclays (Oct 1, 2025) is Outperform/Overweight with a $60 target investing.com, noting that T‑Mobile/Starlink’s $10/mo text service validates AST’s market and that AST’s full voice/data offering “could command higher price points” investing.com. In contrast, UBS recently downgraded ASTS to Neutral (Hold) with a $43 target webull.com, warning that SpaceX’s Starlink has gained a competitive edge.  William Blair initiated coverage at Market Perform za.investing.com. (Other firms have targets in the $40–55 range.) The consensus median target is modestly below current levels, reflecting the uncertain path to big revenues.
  • Competition/Industry: AST operates in a hot “sat-to-cell” field. SpaceX’s Starlink is a primary rival: it has launched >8,000 satellites (with ≈600 optimized for cell service) and in Sept 2025 paid $17 billion for EchoStar’s 20 MHz+ spectrum to supercharge Starlink Direct-to-Cell reuters.com reuters.com. U.S. carriers (T‑Mobile, AT&T) are partnering with Starlink – for example, T‑Mobile’s Starlink-based T-Satellite service expanded on Oct 1, 2025 to support voice/video apps on standard phones t-mobile.com. Legacy satellite carriers (Iridium, Globalstar) are also moving in (e.g. Iridium-backed NTN ventures). ASTS claims its “one-of-a-kind” LEO network (with >3,700 patents) allows it to deliver a native 5G/4G experience on everyday phones businesswire.com, but it must win customers against these giants.
  • Retail/Social Sentiment: ASTS has become a retail favorites. Social media and investor boards are abuzz. For example, QuiverQuant notes that X/Twitter chatter around ASTS was “very excited”, citing BlueBird-6 and carrier deals as evidence of future growth quiverquant.com. StockTwits reported that overnight sentiment turned “bullish”after the launch update, with a 341% spike in message volume stocktwits.com. One StockTwits user even proclaimed holding ASTS as the start of “generational wealth” stocktwits.com. In short, retail momentum is high – but analysts caution that much depends on AST’s ability to execute its satellite rollout and win paying subscribers.

Sources: AST SpaceMobile filings and press releases businesswire.com businesswire.com; Yahoo/BusinessWire news newswire.ca newswire.ca; Investing/Benzinga reports investing.com investing.com; stock market data webull.com stockanalysis.com; Reuters reuters.com reuters.com; and industry media/analyst coverage t-mobile.com webull.com.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Tesla Model 3 vs BYD Seal vs Hyundai Ioniq 6: The Ultimate 2025 EV Showdown—Which One Should You Buy?
Previous Story

Tesla’s Meteoric Momentum: Why Oct. 2, 2025 Could Be a Game‑Changer for TSLA Investors

Rigetti Computing’s Quantum Leap: Stock Soars on Breakthroughs and Bold Bets
Next Story

Rigetti (RGTI) Stock Soars on New Quantum Wins — Breakthrough or Bubble?

Go toTop